Small-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells

Yuan,Jing-Yi; Liu,Li-Ying; Wang,Pei; Li,Zong-Fang; Ni,Lei; Wang,Aiying; Xiao,Sheng-Xiang; Song,Tu-Sheng; Huang,Chen

doi:10.3892/ol_00000114

Small-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells

Authors:
- Jing-Yi Yuan
- Li-Ying Liu
- Pei Wang
- Zong-Fang Li
- Lei Ni
- Aiying Wang
- Sheng-Xiang Xiao
- Tu-Sheng Song
- Chen Huang
View Affiliations

Affiliations: Department of Genetics and Molecular Biology, Medical College of Xi'an Jiaotong University/Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education, Xi'an, Shaanxi 710061, P.R. China
Published online on: July 1, 2010 https://doi.org/10.3892/ol_00000114
Pages: 649-655

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The genesis and progression of cervical cancer involve the mutation or deviant expression of numerous genes, including the activation of oncogenes (Ha-ras, C-myc, C-erbB2 and Bcl-2) and inactivation of tumor-suppressor genes (p53 and Rb). Previous studies showed that small-interfering RNAs (siRNAs) targeting the MAPK p42 gene partly inhibit proliferation and increase apoptosis in human cervical carcinoma HeLa cells. Results of a microarray analysis showed that MAPK p42 siRNA inhibited cell growth through the regulation of cell cycle control and apoptosis and induced interferon-like response in HeLa cells. In order to confirm the dual effects of MAPK p42 siRNA, we compared the roles of siRNA and U0126, an inhibitor of MAPK p42, in HeLa cells. Short 21-mer double-stranded/siRNAs were synthesized to target MAPK p42 mRNA in HeLa cells. The siRNAs were transfected into HeLa cells using Lipofectamine. The cells were treated with siRNA or U0126 at different concentrations for a period of 48 h. The biological effect of siRNA and U0126 on HeLa cells was measured by MTT and flow cytometry. MAPK1, NUP188, P38, STAT1, STAT2, PML and OAS1 were analyzed by real-time quantitative PCR. HeLa cell growth was inhibited by siRNA or U0126, and the effect of siRNA inhibition was greater than that of U0126. Cell cycle phases were different for siRNA or U0126, but HeLa cell growth was arrested at the S phase by siRNA and at G1 phase by U0126. A down-regulation in MAPK p42 expression by siRNA and up-regulation by U0126 were noted. The results of real-time quantitative PCR showed that P38 was up-regulated and NUP188 was down-regulated by siRNA in comparison with the control groups, and the results were consistent with those of U0126. Expression levels of STAT1, STAT2, PML and OAS1 induced by siRNA differed from those induced by U0126. siRNA-mediated silencing and deactivation induced by U0126 in MAPK p42 led to growth inhibition in the HeLa cells. The effects of siRNA on HeLa cell growth were different from those of U0126. Dual effects of MAPK p42 siRNA-2 on HeLa cell growth were noted: one consisted of a specific effect induced by siRNA-mediated p42 MAPK silencing and the other exhibited a non-specific interferon-like response.

View Figures

View References

1	Lohmann JU, Endl I and Bosch TC: Silencing of developmental genes in Hydra. Dev Biol. 214:211–214. 1999. View Article : Google Scholar : PubMed/NCBI
2	Yang D, Lu H and Erickson JW: Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr Biol. 10:1191–1200. 2001. View Article : Google Scholar : PubMed/NCBI
3	Zhao Z, Cao Y, Li M, et al: A double-stranded RAN injection produces nonspecific defects in zebrafish. Dev Biol. 229:215–223. 2001. View Article : Google Scholar : PubMed/NCBI
4	Wianny F and Zernicka-Goetz M: Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol. 2:70–75. 2000. View Article : Google Scholar : PubMed/NCBI
5	Fire A, Xu S, Montgomery MK, et al: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811. 1998. View Article : Google Scholar : PubMed/NCBI
6	Quon K and Kassner PD: RNA interference screening for the discovery of oncology targets. Expert Opin Ther Targets. 13:1027–1035. 2009. View Article : Google Scholar : PubMed/NCBI
7	Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA and Chinnaiyan AM: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419:624–629. 2002. View Article : Google Scholar : PubMed/NCBI
8	Rodríguez-Lebrón E, Gouvion CM, Moore SA, Davidson BL and Paulson HL: Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer’s disease. Mol Ther. 17:1563–1573. 2009.PubMed/NCBI
9	Courties G, Presumey J, Duroux-Richard I, Jorgensen C and Apparailly F: RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin Biol Ther. 9:535–538. 2009. View Article : Google Scholar : PubMed/NCBI
10	Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD and Aronin N: Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington’s disease patients. Curr Biol. 19:774–778. 2009.PubMed/NCBI
11	Paddison PJ, Caudy AA and Hannon GJ: Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA. 99:1443–1448. 2002. View Article : Google Scholar : PubMed/NCBI
12	Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL and Iggo R: Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet. 34:263–264. 2003. View Article : Google Scholar : PubMed/NCBI
13	Sledz CA, Holko M, de Veer MJ, Silverman RH and Williams BR: Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 5:834–839. 2003. View Article : Google Scholar : PubMed/NCBI
14	Boulton TG, Nye SH, Robbins DJ, et al: ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:663–675. 1991. View Article : Google Scholar : PubMed/NCBI
15	Derijard B, Hibi M, Wu IH, et al: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1025–1037. 1994. View Article : Google Scholar : PubMed/NCBI
16	Han J, Lee JD, Bibbs L, et al: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:808–811. 1994. View Article : Google Scholar : PubMed/NCBI
17	Kyriakis JM and Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 81:807–869. 2001.PubMed/NCBI
18	Huang C, Liu LY, Song TS, et al: Small interfering RNA-mediated MAPK p42 silencing induces apoptosis of HeLa cells. Nan Fang Yi Ke Da Xue Xue Bao. 26:11–15. 2006.PubMed/NCBI
19	Liu L, Huang C, Li Z, et al: Related genes for HeLa cell apoptosis induced by siRNA-mediated MAPK p42 silencing. Acta Med Univ Sci Technol Huazhong. 37:129–132. 2008.
20	Huang C, Liu L, Li Z, et al: Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis. Cell Biol Int. 32:1081–1090. 2008. View Article : Google Scholar : PubMed/NCBI
21	Staber PB, Linkesch W, Zauner D, Beham-Schmid C, Guelly C, Schauer S, Sill H and Hoefler G: Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia. Oncogene. 23:894–904. 2004. View Article : Google Scholar : PubMed/NCBI
22	Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, van den Beldt K, Duesbery NS, Resau JH and Teh BT: Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res. 68:81–88. 2008. View Article : Google Scholar : PubMed/NCBI
23	Salh B, Marotta A, Matthewson C, Ahluwalia M, Flint J, Owen D and Pelech S: Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer. Anticancer Res. 19:731–740. 1999.PubMed/NCBI
24	Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL and Pescovitz OH: Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol. 18:2570–2582. 2004. View Article : Google Scholar
25	Tamemoto H, Kadowaki T, Tobe K, Ueki K, Izumi T, Chatani Y, Kohno M, Kasuga M, Yazaki Y and Akanuma Y: Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J Biol Chem. 267:20293–20297. 1992.PubMed/NCBI
26	Bradham C and McClay DR: p38 MAPK in development and cancer. Cell Cycle. 5:824–828. 2006. View Article : Google Scholar : PubMed/NCBI
27	Parameswaran N, Nambi P, Hall CS, Brooks DP and Spielman WS: Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells. Eur J Pharmacol. 388:133–138. 2000. View Article : Google Scholar
28	Sen GC: Viruses and interferons. Annu Rev Microbiol. 55:255–281. 2001. View Article : Google Scholar : PubMed/NCBI
29	Saunders LR and Barber GN: The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17:961–983. 2003. View Article : Google Scholar : PubMed/NCBI
30	Hovanessian AG and Justesen J: The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie. 89:779–788. 2007.
31	Boese A, Sommer P, Gaussin A, Reimann A and Nehrbass U: Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with integration. FEBS Lett. 578:291–296. 2004. View Article : Google Scholar : PubMed/NCBI
32	Heidel JD, Hu S, Liu XF, Triche TJ and Davis ME: Lack of interferon response in animals to naked siRNAs. Nat Biotechnol. 22:1579–1582. 2004. View Article : Google Scholar : PubMed/NCBI
33	Sledz CA and Williams BR: RNA interference and double-stranded-RNA-activated pathways. Biochem Soc Trans. 32:952–956. 2004. View Article : Google Scholar : PubMed/NCBI
34	Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X and Blandino G: PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell. 32:803–814. 2008. View Article : Google Scholar : PubMed/NCBI
35	Youlyouz-Marfak I, Gachard N, Le Clorennec C, Najjar I, Baran-Marszak F, Reminieras L, May E, Bornkamm GW, Fagard R and Feuillard J: Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death Differ. 15:376–385. 2008. View Article : Google Scholar : PubMed/NCBI
36	Negoro S, Kunisada K, Tone E, et al: Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res. 47:797–805. 2000. View Article : Google Scholar : PubMed/NCBI